[{"Assets_0_Q2_USD":7646945000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":198345000.0,"NetIncomeLossConverted_1_Q2_USD":598810000.0,"NetIncomeLossConverted_2_Q2_USD":1464005000.0,"StockholdersEquity_0_Q2_USD":5486810000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":30154000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":30125000.0,"EarningsPerShareBasic_1_Q2_USD":20.08,"EarningsPerShareBasic_2_Q2_USD":49.12,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":29814000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29807000.0,"EarningsPerShareDiluted_1_Q2_USD":19.86,"EarningsPerShareDiluted_2_Q2_USD":48.6,"RevenuesConverted_1_Q2_USD":572619000.0,"RevenuesConverted_2_Q2_USD":1126598000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20190806"}]